Intraoperative subcutaneous or intrasplenic vaccination with modified autologous tumor cells leads to enhanced survival in a mouse tumor model

Author: Dietrich Arne   Stockmar Christoph   Aust Gabriela   Endesfelder Susan   Guetz Anke   Sack Ulrich   Schoenfelder Manfred   Hauss Johann  

Publisher: Springer Publishing Company

ISSN: 0171-5216

Source: Journal of Cancer Research and Clinical Oncology, Vol.132, Iss.6, 2006-06, pp. : 379-388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content